Southeast Asia countries 2026 latest financial compliance regulations, regulatory policy changes and industry adaptation strategies....
Banking basics, rate comparison tutorials and financial risk education
Cross-border financial services, remittance and trade finance across Asia
Digital banking development, fintech innovation and virtual bank licenses in Asia
Latest updates on Asian banking industry across Singapore, Hong Kong, Malaysia, Thailand, Vietnam and Indonesia
On August 19, 2026, the precious metals market experienced sharp volatility, with gold prices breaking the $4600 mark and silver hitting a 3-year high. This article delves into the impact of factors like Fed rate cut expectations, geopolitical conflicts, and industrial demand on precious metal prices, offering investors the latest market dynamics and investment strategy advice.
2026-08-19On July 28, 2026, international gold price broke above $4,350/oz, hitting a record high. Sustained central bank gold reserve additions, escalating Middle East geopolitical conflicts, and strong physical demand jointly drove the surge. Silver rallied in tandem, with the gold-silver ratio declining. Analysts pointed out that gold's monetary and safe-haven attributes are being repriced in the current macroeconomic environment.
2026-07-28During Wednesday's Asian trading session, spot gold rebounded strongly to around $4,120, driven by global risk aversion and geopolitical tensions. This article analyzes the reasons for the gold price rise and future trends from multiple dimensions: geopolitical risks, macro policies, market sentiment, and technical aspects.
2026-07-24Precious metals rebounded as bargain buying pushed spot silver up 2.3% to $60 and platinum up 3% to $1,625.83. Analysis of Fed policy expectations and the market tug-of-war.
2026-07-13The international gold market has seen a strong rebound, driven by Middle East geopolitical tensions and dip buying, but expectations of Fed rate hikes are limiting the upside. Next week's U.S. inflation data and Fed Chair Wosh's congressional testimony will be key signposts, and investors should watch closely.
2026-07-13Libang Medical-B (09637.HK) listed on HKEX with a 963x oversubscription in its public offer and an 88% gray market gain. The company focuses on kidney disease with differentiated biopharma pipelines. This analysis covers IPO details, business strategy, and investment outlook.
2026-06-29Click tags to browse more related information
